Pernix Therapeutics Holdings Inc (NASDAQ:PTX)

2.39
Delayed Data
As of Feb 16
 +0.01 / +0.42%
Today’s Change
2.00
Today|||52-Week Range
7.15
-0.42%
Year-to-Date
No recent news for Pernix Therapeutics Holdings Inc.

Today’s Trading

Previous close2.38
Today’s open2.36
Day’s range2.36 - 2.41
Volume286,466
Average volume (3 months)135,320
Market cap$27.6M
Data as of 4:00pm ET, 02/16/2018

Growth & Valuation

Earnings growth (last year)+22.05%
Earnings growth (this year)+25.93%
Earnings growth (next 5 years)+13.60%
Revenue growth (last year)-19.90%
P/E ratioNM
Price/Sales0.11
Price/Book--

Competitors

 Today’s
change
Today’s
% change
TPIVTapImmune Inc-0.18-5.54%
ZSANZosano Pharma Corp-0.00-0.12%
PULMPulmatrix Inc-0.05-3.27%
NTRPNeurotrope Inc+0.29+3.45%
Data as of 3:59pm ET, 02/16/2018

Financials

Next reporting dateMarch 28, 2018
EPS forecast (this quarter)-$3.90
Annual revenue (last year)$140.9M
Annual profit (last year)-$169.6M
Net profit margin-120.40%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
John A. Sedor
Secretary, Chief Legal &
Compliance Officer, SVP
Kenneth R. Piña
Corporate headquarters
Morristown, New Jersey

Forecasts